On September 16, 2025, Biofrontera Inc. held a special stockholders meeting where several proposals were approved, including a reverse stock split to comply with Nasdaq listing requirements and issuance of common stock for Series C and D preferred stock conversions. The meeting had a quorum, with over 8.4 million votes recorded in favor of the proposals.